- Home
- KG vs ABVC Comparison
KG vs ABVC Comparison
Compare KG & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KG | ABVC |
|---|---|---|
| Founded | N/A | 2015 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.0M | 26.7M |
| IPO Year | 2025 | 2009 |
Fundamental Metrics
Financial Performance| Metric | KG | ABVC |
|---|---|---|
| Price | $3.94 | $0.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.2K | ★ 30.5K |
| Earning Date | 11-06-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1819.15 | 7.14 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $34,049,000.00 | $509,589.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $171.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 785.08 | N/A |
| 52 Week Low | $3.74 | $0.71 |
| 52 Week High | $16.18 | $3.06 |
Technical Indicators
Market Signals| Indicator | KG | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 34.40 | 43.20 |
| Support Level | N/A | $0.92 |
| Resistance Level | $5.54 | $1.13 |
| Average True Range (ATR) | 0.33 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 4.72 | 5.89 |
Price Performance
Historical ComparisonAbout KG Kestrel Group Ltd.
Kestrel Group Ltd specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers with two reportable segments: Program Services and Legacy Reinsurance. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.